Ligand Design for Cereblon Based Immunomodulatory Therapy.
作者： Robert B. Kargbo
DOI: 10.1021/ACSMEDCHEMLETT.0C00214
关键词:
摘要:
acs.org
sci-hub.se 参考文章(5)
Jianping Guo, Jing Liu, Wenyi Wei, Degrading proteins in animals: "PROTAC"tion goes in vivo. Cell Research. ,vol. 29, pp. 179- 180 ,(2019) , 10.1038/S41422-019-0144-9
Shaobing Gao, Shichao Wang, Yongping Song, Novel immunomodulatory drugs and neo-substrates Biomarker research. ,vol. 8, pp. 1- 8 ,(2020) , 10.1186/S40364-020-0182-Y
George M. Burslem, Craig M. Crews, Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery Cell. ,vol. 181, pp. 102- 114 ,(2020) , 10.1016/J.CELL.2019.11.031
Hongying Gao, Xiuyun Sun, Yu Rao, PROTAC Technology: Opportunities and Challenges ACS Medicinal Chemistry Letters. ,vol. 11, pp. 237- 240 ,(2020) , 10.1021/ACSMEDCHEMLETT.9B00597
Lisa C. Holthof, Tuna Mutis, Challenges for Immunotherapy in Multiple Myeloma: Bone Marrow Microenvironment-Mediated Immune Suppression and Immune Resistance Cancers. ,vol. 12, pp. 988- ,(2020) , 10.3390/CANCERS12040988